NEW YORK CITY, NY / ACCESS Newswire / October 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Brunello Cucinelli S.p.A. ("Brunello Cucinelli" or the "Company") (OTCMKTS:BCUCY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Brunello Cucinelli and certain of its […]

NEW YORK CITY, NY / ACCESS Newswire / October 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Firefly Aerospace Inc. ("Firefly" or the "Company") (NASDAQ:FLY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Firefly and certain of its officers and/or

(NYSE:PFS), ISELIN, N.J., Oct. 01, 2025 (GLOBE NEWSWIRE) — Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended September 30, 2025 on Wednesday, October 29, 2025 after market close. A copy of the earnings release will be immediately available on the Company's website, www.Provident.Bank, by going

Provident Financial Services, Inc. Schedules Third Quarter Earnings Conference Call GlobeNewswire October 01, 2025 ISELIN, N.J., Oct. 01, 2025 (GLOBE NEWSWIRE) — Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended September 30, 2025 on Wednesday, October 29, 2025 after market close. A copy of the

(NASDAQ:CYTK), NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the “Class Period”), of the important November 17, 2025 lead plaintiff deadline. SO WHAT: If

(NYSE:DHR), NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR). If you currently own shares of Danaher stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=17717 for more information. You

NATIONALLY RANKED ROSEN LAW FIRM Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK GlobeNewswire October 01, 2025 NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR GlobeNewswire October 01, 2025 NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation

(TSX-V:CRI), TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) — Further to its news release of September 16, 2025, Churchill Resources Inc. (“Churchill” or the “Company“) (TSXV: CRI) is pleased to announce the closing of its previously announced non-brokered private placement, consisting of the sale of 37,500,000 common shares of the Company (the “Shares“) at a price

Churchill Resources Announces Completion of $3,000,000 Private Placement GlobeNewswire October 01, 2025 TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) — Further to its news release of September 16, 2025, Churchill Resources Inc. (“Churchill” or the “Company“) (TSXV: CRI) is pleased to announce the closing of its previously announced non-brokered private placement, consisting of the sale of